XTL Biopharma Sets Shareholder Meeting for July 21
Ticker: XTLB · Form: 6-K · Filed: Jun 13, 2025 · CIK: 1023549
| Field | Detail |
|---|---|
| Company | Xtl Biopharmaceuticals Ltd (XTLB) |
| Form Type | 6-K |
| Filed Date | Jun 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance
TL;DR
XTL Bio shareholders meeting July 21st to vote on key company decisions.
AI Summary
XTL Biopharmaceuticals Ltd. announced on June 13, 2025, that it will hold its Annual and Extraordinary General Meeting of Shareholders on July 21, 2025. The meeting will take place at 4:00 p.m. Israel time at the Company's principal executive offices located at 26 Ben-Gurion St., Ramat Gan, Israel.
Why It Matters
This meeting is crucial for shareholders to vote on important company matters and elect directors, impacting the company's future direction and governance.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a shareholder meeting and does not contain new financial or operational risks.
Key Players & Entities
- XTL Biopharmaceuticals Ltd. (company) — Registrant
- June 13, 2025 (date) — Announcement Date
- July 21, 2025 (date) — Shareholder Meeting Date
- 4:00 p.m. Israel time (time) — Shareholder Meeting Time
- 26 Ben-Gurion St., Ramat Gan, Israel (location) — Company Principal Executive Offices
FAQ
When will XTL Biopharmaceuticals Ltd. hold its Annual and Extraordinary General Meeting of Shareholders?
The meeting is scheduled for July 21, 2025.
What time is the shareholder meeting scheduled to begin?
The meeting will commence at 4:00 p.m. Israel time.
Where will the Annual and Extraordinary General Meeting of Shareholders be held?
The meeting will be held at the Company's principal executive offices at 26 Ben-Gurion St., Ramat Gan, Israel.
What type of meeting is XTL Biopharmaceuticals Ltd. announcing?
The company is announcing an Annual and Extraordinary General Meeting of Shareholders.
What is the exact date of the announcement for the shareholder meeting?
The announcement was made on June 13, 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 13, 2025 regarding XTL BIOPHARMACEUTICALS LTD (XTLB).